Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Clinical trial NCT07093411 · RECRUITING

Trial details

NCT number: NCT07093411
Sponsor: Beijing GoBroad Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

B-cell Non-Hodgkin Lymphoma Recurrent B-cell Non-Hodgkin Lymphoma Refractory

Start date: 2025-08-05
Primary completion: 2028-08-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.